Cumberland Pharmaceuticals Inc SEC filings CPIX
Cumberland Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to Mar 18, 2009. Its latest annual report, Form ARS, was filed on Mar 12, 2026 for the period ended Mar 12, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 26, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Other events
|
Oct 23, 2026 | Oct 23, 2026 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Sep 11, 2026 | Apr 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 28, 2026 | Aug 28, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Other events
|
Jul 13, 2026 | Jul 13, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Officer or director change, Other events
|
Jul 1, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2026 | Jun 24, 2026 |
| DEFM14A | Filing | May 26, 2026 | — |
| PREM14A | Filing | May 15, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Apr 24, 2026 | Apr 21, 2026 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Apr 23, 2026 | Apr 22, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| ARS | Annual report to shareholders | Mar 12, 2026 | Mar 12, 2026 |
| DEFA14A | Additional proxy material | Mar 9, 2026 | — |
| DEF 14A | Proxy statement | Mar 9, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 9, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2026 | Mar 3, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 9, 2026 | — |
| 8-K |
Current report
Other events
|
Feb 4, 2026 | Feb 4, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Dec 1, 2025 |
| 4 | Insider transaction | Jan 6, 2026 | Dec 1, 2025 |
| 4 | Insider transaction | Jan 6, 2026 | Dec 1, 2025 |
| 4 | Insider transaction | Jan 6, 2026 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 1, 2025 | Nov 3, 2025 |
| 4 | Insider transaction | Dec 1, 2025 | Nov 3, 2025 |
| 4 | Insider transaction | Dec 1, 2025 | Nov 3, 2025 |
| 4 | Insider transaction | Dec 1, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 24, 2025 | Nov 18, 2025 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 4 | Insider transaction | Nov 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Nov 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Nov 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Nov 3, 2025 | Oct 1, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 30, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 21, 2025 | Oct 21, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Sep 12, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Sep 12, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Sep 12, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Sep 12, 2025 | Aug 1, 2025 |
| UPLOAD | Letter from the SEC | Aug 25, 2025 | — |
| CORRESP | Letter to the SEC | Aug 15, 2025 | — |
| 4 | Insider transaction | Aug 11, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Aug 11, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Aug 11, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Aug 11, 2025 | Jul 1, 2025 |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| UPLOAD | Letter from the SEC | Aug 4, 2025 | — |
| 4 | Insider transaction | Jul 11, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Jul 11, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Jul 11, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Jul 11, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | May 1, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | May 1, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | May 1, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | May 1, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| 4 | Insider transaction | May 9, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | May 9, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | May 9, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | May 9, 2025 | Apr 1, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Apr 28, 2025 | Apr 28, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 24, 2025 | — |
| 4 | Insider transaction | Apr 4, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Apr 4, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Apr 4, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Apr 4, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Other events
|
Mar 19, 2025 | Mar 19, 2025 |
| ARS | Annual report to shareholders | Mar 18, 2025 | Mar 18, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 16, 2025 |
| DEFA14A | Additional proxy material | Mar 10, 2025 | — |
| DEF 14A | Proxy statement | Mar 10, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 7, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 4, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Other events
|
Feb 19, 2025 | Feb 19, 2025 |
| 424B5 | Prospectus supplement | Feb 14, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 14, 2025 | Feb 14, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 13, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 11, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 4, 2025 | Feb 4, 2025 |
| 4/A | Form 4/a | Jan 30, 2025 | Mar 25, 2024 |
| 4/A | Form 4/a | Jan 30, 2025 | Mar 25, 2024 |
| 4/A | Form 4/a | Jan 30, 2025 | Mar 25, 2024 |
| 4/A | Form 4/a | Jan 30, 2025 | Mar 25, 2024 |
| 4/A | Form 4/a | Jan 30, 2025 | Mar 25, 2024 |
| 4 | Insider transaction | Dec 30, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 30, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 30, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 30, 2024 | Dec 2, 2024 |
| 8-K |
Current report
Other events
|
Dec 9, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 5, 2024 | Nov 1, 2024 |
| 4 | Insider transaction | Dec 5, 2024 | Nov 1, 2024 |
| 4 | Insider transaction | Dec 5, 2024 | Nov 1, 2024 |
| 4 | Insider transaction | Dec 5, 2024 | Nov 1, 2024 |
| 8-K |
Current report
Other events
|
Nov 12, 2024 | Nov 6, 2024 |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Other events
|
Nov 6, 2024 | Nov 6, 2024 |
| 4 | Insider transaction | Nov 5, 2024 | Oct 1, 2024 |
| 4 | Insider transaction | Nov 5, 2024 | Oct 1, 2024 |
| 4 | Insider transaction | Nov 5, 2024 | Oct 1, 2024 |
| 4 | Insider transaction | Nov 5, 2024 | Oct 1, 2024 |
| 8-K |
Current report
Other events
|
Nov 4, 2024 | Nov 4, 2024 |
| 4 | Insider transaction | Oct 3, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Oct 3, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Oct 3, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Oct 3, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Aug 1, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Aug 1, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Aug 1, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Aug 1, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Aug 1, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 4 | Insider transaction | Aug 2, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Aug 2, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Aug 2, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Aug 2, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 13, 2024 |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Apr 29, 2024 | Apr 29, 2024 |
| 4 | Insider transaction | Mar 26, 2024 | Mar 25, 2024 |
| 4 | Insider transaction | Mar 26, 2024 | Mar 25, 2024 |
| 4 | Insider transaction | Mar 26, 2024 | Mar 25, 2024 |
| 4 | Insider transaction | Mar 26, 2024 | Mar 25, 2024 |
| 4 | Insider transaction | Mar 26, 2024 | Mar 25, 2024 |
| 4 | Insider transaction | Mar 26, 2024 | Mar 23, 2024 |
| 4 | Insider transaction | Mar 26, 2024 | Mar 23, 2024 |
| 4 | Insider transaction | Mar 26, 2024 | Mar 23, 2024 |
| 4 | Insider transaction | Mar 26, 2024 | Mar 23, 2024 |
| 4 | Insider transaction | Mar 26, 2024 | Mar 23, 2024 |
| ARS | Annual report to shareholders | Mar 22, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Mar 20, 2024 | Mar 20, 2024 |
| 424B5 | Prospectus supplement | Mar 20, 2024 | — |
| DEFA14A | Additional proxy material | Mar 13, 2024 | — |
| DEF 14A | Proxy statement | Mar 13, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 13, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2024 | Mar 5, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2024 | — |
| 4 | Insider transaction | Dec 28, 2023 | Dec 1, 2023 |
| 4 | Insider transaction | Dec 28, 2023 | Dec 1, 2023 |
| 4 | Insider transaction | Dec 28, 2023 | Dec 1, 2023 |
| 4 | Insider transaction | Dec 28, 2023 | Dec 1, 2023 |
| EFFECT | Filing | Dec 26, 2023 | — |
| CORRESP | Letter to the SEC | Dec 21, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2023 | — |
| DEL AM | Filing | Dec 15, 2023 | — |
| S-3 | Shelf registration | Dec 14, 2023 | — |
| 4 | Insider transaction | Dec 6, 2023 | Nov 27, 2023 |
| 4 | Insider transaction | Dec 6, 2023 | Nov 1, 2023 |
| 4 | Insider transaction | Dec 6, 2023 | Nov 1, 2023 |
| 4 | Insider transaction | Dec 6, 2023 | Nov 1, 2023 |
| 4/A | Primary document | Dec 6, 2023 | Nov 16, 2023 |
| 4 | Insider transaction | Nov 17, 2023 | Nov 1, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 4 | Insider transaction | Nov 3, 2023 | Oct 2, 2023 |
| 4 | Insider transaction | Nov 3, 2023 | Oct 2, 2023 |
| 4 | Insider transaction | Nov 3, 2023 | Oct 2, 2023 |
| 4 | Insider transaction | Nov 3, 2023 | Oct 17, 2023 |
| 4 | Insider transaction | Oct 17, 2023 | Oct 2, 2023 |
| 8-K |
Current report
Other events
|
Oct 13, 2023 | Oct 13, 2023 |
| 4 | Insider transaction | Oct 3, 2023 | Sep 5, 2023 |
| 4 | Insider transaction | Oct 3, 2023 | Sep 5, 2023 |
| 4 | Insider transaction | Oct 3, 2023 | Sep 18, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CPIX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TN
- Headquarters
- Nashville,, TN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1087294
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.